Cargando…

Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19

The appearance of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of effective antiviral therapeutics for coronavirus disease 2019 (COVID-19), a highly infectious disease caused by the virus, demands the search for alternative therapies. Most antiviral drugs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gurung, Arun Bahadur, Ali, Mohammad Ajmal, Lee, Joongku, El-Zaidy, Mohamed, Aljowaie, Reem M., Almutairi, Saeedah M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165783/ https://www.ncbi.nlm.nih.gov/pubmed/35657783 http://dx.doi.org/10.1371/journal.pone.0268919

Ejemplares similares

Exploring the phytochemicals of Platycodon grandiflorus for TMPRSS2 inhibition in the search for SARS-CoV-2 entry inhibitors
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

Masitinib analogues with the N-methylpiperazine group replaced – A new hope for the development of anti-COVID-19 drugs
por: Gurung, Arun Bahadur, et al.
Publicado: (2023)

In silico analyses of major active constituents of fingerroot (Boesenbergia rotunda) unveils inhibitory activities against SARS-CoV-2 main protease enzyme
por: Bahadur Gurung, Arun, et al.
Publicado: (2022)

An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 omicron inhibitors
por: Bahadur Gurung, Arun, et al.
Publicado: (2022)

Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp
por: Gurung, Arun Bahadur, et al.
Publicado: (2021)

Insights into plastome of Fagonia indica Burm.f. (Zygophyllaceae): organization, annotation and phylogeny
por: Elshikh, Mohamed S., et al.
Publicado: (2022)

Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
por: Gurung, Arun Bahadur, et al.
Publicado: (2021)

Identification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb.
por: Bahadur Gurung, Arun, et al.
Publicado: (2021)

Retraction: Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19
Publicado: (2022)

Artesunate induces substantial topological alterations in the SARS-CoV-2 Nsp1 protein structure
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme
por: Bahadur Gurung, Arun, et al.
Publicado: (2020)

Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

Detection of the peptidyl epitope for vaccine development against MPV
por: Sarkar, Indrani, et al.
Publicado: (2023)

In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors
por: Gurung, Arun Bahadur
Publicado: (2020)

In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19
por: Gurung, Arun Bahadur, et al.
Publicado: (2021)

Molecular docking and dynamics simulation study of bioactive compounds from Ficus carica L. with important anticancer drug targets
por: Gurung, Arun Bahadur, et al.
Publicado: (2021)

The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Molecular modelling studies unveil potential binding sites on human serum albumin for selected experimental and in silico COVID-19 drug candidate molecules
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

Molecular docking elucidates the plausible mechanisms underlying the anticancer properties of acetyldigitoxigenin from Adenium obesum
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

Transcriptome characterization of Larrea tridentata and identification of genes associated with phenylpropanoid metabolic pathways
por: Ali, Mohammad Ajmal, et al.
Publicado: (2022)

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
por: Abbott, Timothy R., et al.
Publicado: (2020)

The cp genome characterization of Adenium obesum: Gene content, repeat organization and phylogeny
por: Alanazi, Khalid Mashay, et al.
Publicado: (2021)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022)

Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2
por: Hussein, Mouraya, et al.
Publicado: (2023)

Binding of small molecules at interface of protein–protein complex – A newer approach to rational drug design
por: Gurung, A.B., et al.
Publicado: (2017)

Photodynamic Inactivation of SARS-CoV-2 Infectivity and Antiviral Treatment Effects In Vitro
por: Ziganshyna, Svitlana, et al.
Publicado: (2022)

Potential antiviral peptides against the nucleoprotein of SARS-CoV-2
por: Mahdi, Iktedar, et al.
Publicado: (2022)

Plastome of Saraca asoca (Detarioideae, Fabaceae): Annotation, comparison among subfamily and molecular typing
por: Ali, Mohammad Ajmal, et al.
Publicado: (2021)

Effectiveness of Remdesivir in Comparison with Five Approved Antiviral Drugs for Inhibition of RdRp in Combat with SARS-CoV-2
por: Mahdian, Soodeh, et al.
Publicado: (2022)

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
por: Johansen-Leete, Jason, et al.
Publicado: (2022)

Nonthermal Biocompatible Plasma Inactivation of Coronavirus SARS-CoV-2: Prospects for Future Antiviral Applications
por: Han, Ihn, et al.
Publicado: (2022)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
por: Tonk, Miray, et al.
Publicado: (2021)

Potential antiviral peptides targeting the SARS-CoV-2 spike protein
por: Khater, Ibrahim, et al.
Publicado: (2022)

Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
por: Saini, Jasleen, et al.
Publicado: (2022)

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
por: Essa, Raahilah Zahir, et al.
Publicado: (2022)

The nsp15 Nuclease as a Good Target to Combat SARS-CoV-2: Mechanism of Action and Its Inactivation with FDA-Approved Drugs
por: Saramago, Margarida, et al.
Publicado: (2022)

Molecular docking analysis of novel quercetin derivatives for combating SARS-CoV-2
por: K. Hussein, Rageh, et al.
Publicado: (2023)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i12sjd10ck8c6qgaf9hns4b4s1